Risk of Non-melanoma Skin Cancer in Patients with Chronic Kidney Disease and its Relationship to Uraemic Pruritus

Acta Derm Venereol. 2017 Nov 15;97(10):1230-1234. doi: 10.2340/00015555-2762.

Abstract

This study investigated the risk of non-melanoma skin cancer (NMSC) in pre-dialysis patients with chronic kidney disease (CKD) and explored associated risk factors. A population-based cohort of 1,515,858 Taiwanese CKD patients was included. The standardized incidence ratio (SIR) for incident NMSC was determined. Compared with the general population, a 1.14-fold risk of NMSC was found in the CKD cohort. NMSC risk was significant in patients with pre-dialysis stage 5 CKD and anaemia (1.48-fold), and in those with uraemic pruritus after long-term antihistamine treatment (1.38-fold). A higher SIR for NMSC was found in younger patients with CKD (age < 70 years, 1.34-fold; age 20-39 years, 1.63-fold), stage 5 CKD with anaemia (age < 70 years, 2.09-fold), and uraemic pruritus (age <70 years, 2.22-fold). Pre-dialysis patients with CKD are at higher risk of NMSC, especially those with advanced-stage CKD, and those with uraemic pruritus.

MeSH terms

  • Adult
  • Aged
  • Databases, Factual
  • Female
  • Histamine Antagonists / therapeutic use
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Prognosis
  • Pruritus / diagnosis
  • Pruritus / drug therapy
  • Pruritus / epidemiology*
  • Renal Insufficiency, Chronic / diagnosis
  • Renal Insufficiency, Chronic / epidemiology*
  • Risk Assessment
  • Risk Factors
  • Severity of Illness Index
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / epidemiology*
  • Taiwan / epidemiology
  • Time Factors
  • Uremia / diagnosis
  • Uremia / epidemiology*
  • Young Adult

Substances

  • Histamine Antagonists